An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
The best way to predict which patients will suffer chronic pain after surgery is to ask them how they're feeling, Stanford researchers find.
At a recent Stanford Health Policy Forum, researchers Anne Case and Rebecca Bernert discussed suicide in the United States.
Someone born with a relatively simple heart problem, even when it's fixed by surgery, is 13 times as likely to later develop heart failure.
A Stanford clinic found that staying in close contact with patients virtually between appointments achieved dramatic health improvements. Can additional technology build on those gains?
In most babies and kids, the sound of their mother's voice gets special treatment in the brain. But in autism, this distinctive brain response is lessened.
Orthopaedic surgeon Constance Chu has spent her career seeking ways to prevent osteoarthritis from developing after a knee injury.
A new study has found that opioid-related deaths are highest on the East Coast and opioids are affecting an increasing number of African-Americans.
A baby born with a rare heart complication is now thriving following two surgeries at Lucile Packard Children's Hospital Stanford.
Nurse-scientist Kimberly Pyke-Grimm draws on her clinical experience when studying how teens, young adults and families make decisions about cancer care.
This challenge asks participants to recognize when negative thoughts are occurring and try to diffuse them when they turn worrisome or distracting.
More than a third of patients who are prescribed statins fail to take them regularly, and they are dying at higher rates as a result.
If you happened to have dropped by the Apple Store in downtown San Francisco Monday evening, you might have caught sight of something out of …
A Stanford researcher has found that patients with heart failure, even if it's relatively mild, are more likely to die within three months after surgery.
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
Experts studying nicotine and e-cigarette norms say that Juul has instigated a "nicotine arms race," causing a shift across the e-cigarette industry.